This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Winners and Losers: Regeneron

TiVo (TIVO - Get Report) soared 24.8%, a day after the digital video recorders maker reported narrower-than-expected loss in the third quarter and guided in line with analysts' expectations for the current quarter. TiVo lost $8.2 million, or 8 cents a share, in the quarter compared with a loss of $11.1 million, or 12 cents a share a year ago. Analysts were expecting a loss of 13 cents a share. Revenue rose to $58.3 million, higher than Street expectations of $56.7 million.

TiVo also received an upgrade Thursday from JPMorgan, which now rates the stock overweight from underweight. TiVo also said Thursday it has won a decision in its favor from the U.S. Patent and Trademark Office in a dispute against EchoStar (DISH). Shares of TiVo were up $1.48 to $7.46.

Also on the rise was Regeneron (REGN - Get Report), shares of which garnered $4.86, or 28.3%, to $21.80 on news that it strengthened its ties with Sanofi-Aventis (SNY). Sanofi now holds a 19% stake in the company, up from a prior 4% stake. The team's new collaboration will use Regeneron technology to discover and develop fully humanized antibody drugs.

Chinese gaming company Shanda Interactive (SNDA) gave up some of the gains from its third-quarter earnings report on Tuesday. Shanda had announced earnings of 44 cents a share on revenue of $87.4 million, compared to analysts' expectations of 43 cents a share on revenue of $82 million. The stock fell $2.11, or 5.4%, to $36.89 Thursday.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AMGN $158.30 0.00%
CTR $12.10 0.00%
REGN $376.71 0.00%
TIVO $9.98 0.00%
AAPL $93.74 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs